Gores offers to offload photopheresis business from J&J's Dx unit
This article was originally published in Clinica
Executive Summary
Private equity firm The Gores Group has made a binding offer to acquire from Ortho-Clinical Diagnostics its Therakos division, which specialises in extracorporeal photopheresis (ECP) for treating a type of blood cancer.